Stock Events

Stock Events

Braxia Scientific 

C$0.005000
28
-C$0.00-0%Friday 13:30

Statistics

Day High
0.005
Day Low
0.005
52W High
0.005
52W Low
0.005
Volume
0
Avg. Volume
0
Mkt Cap
1.32M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Aug 27Expected
Q4 2022
Q2 2023
Q3 2023
Q4 2023
Q2 2024
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-697.51%Profit Margin
Unprofitable
2019
2020
2021
2022
1.88MRevenue
-13.14MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BRAX.CN. It's not an investment recommendation.
Apple
5
AAPL
Microsoft
5
MSFT
AT&T
5
T
Tesla
4
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.6B
Compass Pathways operates in the psychedelic medicine space, focusing on psilocybin therapy for depression, directly competing with Braxia's ketamine treatments for similar mental health conditions.
GH Research
GHRS
Mkt Cap1.43B
GH Research is involved in the development of therapeutics based on psychedelic substances for mental health disorders, competing in the same emerging sector as Braxia.
AtaiBeckley
ATAI
Mkt Cap2.73B
ATAI Life Sciences is a biotech company with a focus on psychedelic and digital therapeutics for mental health, making it a direct competitor in the psychedelic treatment market.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness focuses on psychedelic production and therapy, including mental health treatments, positioning it as a competitor in the same niche as Braxia.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics explores the use of psychedelics in treatments for various disorders, including mental health, which competes with Braxia's focus areas.

About

Braxia Scientific Corp. is a medical research enterprise that runs clinics specializing in ketamine-based treatments for individuals facing depression and related conditions. The company further operates a network of multidisciplinary clinics dedicated to addressing a wide spectrum of mental health disorders. Beyond its clinical services, Braxia is actively engaged in research and development, striving to discover and commercialize novel pharmaceutical compounds and advanced delivery systems. Utilizing its intellectual property development platform, it focuses on the creation and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products. The firm's corporate headquarters are located in Toronto, Ontario.
Show More
CEO
Peter Rizakos
Employees
5
Country
Canada
ISIN
CA1057361026
WKN
000A3CPBM

Listings

MU
DE
4960.MU
CN
CA
SHRM.CN
OTC Link
US
BRAXF
CN
CA
BRAX.CN

0 Comments

Share your thoughts

FAQs

What is Braxia Scientific stock price today?▼
The current price of BRAX.CN is C$0.00 CAD — it has decreased by -0% in the past 24 hours. Watch Braxia Scientific stock price performance more closely on the chart.
What is Braxia Scientific stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Canadian Securities Exchange exchange Braxia Scientific stocks are traded under the ticker BRAX.CN.
What is Braxia Scientific market cap?▼
Today Braxia Scientific has the market capitalization of 1.32M
What is Braxia Scientific revenue for the last year?▼
Braxia Scientific revenue for the last year amounts to 1.88M CAD.
What is Braxia Scientific net income for the last year?▼
BRAX.CN net income for the last year is -13.14M CAD.
How many employees does Braxia Scientific have?▼
As of November 3, 2026, the company has 5 employees.
In which sector is Braxia Scientific located?▼
Braxia Scientific operates in the Health & Wellness sector.
When did Braxia Scientific complete a stock split?▼
Braxia Scientific has not had any recent stock splits.
Where is Braxia Scientific headquartered?▼
Braxia Scientific is headquartered in Toronto, Canada.